175 related articles for article (PubMed ID: 34709784)
1. In Vitro and In Vivo of Triphenylamine-Appended Fluorescent Half-Sandwich Iridium(III) Thiosemicarbazones Antitumor Complexes.
Shao M; Yao M; Liu X; Gao C; Liu W; Guo J; Zong J; Sun X; Liu Z
Inorg Chem; 2021 Nov; 60(22):17063-17073. PubMed ID: 34709784
[TBL] [Abstract][Full Text] [Related]
2. Triphenylamine-appended cyclometallated iridium(III) complexes: Preparation, photophysical properties and application in biology/luminescence imaging.
Liu X; Hao H; Ge X; He X; Liu Y; Wang Y; Wang H; Shao M; Jing Z; Tian L; Liu Z
J Inorg Biochem; 2019 Oct; 199():110757. PubMed ID: 31445461
[TBL] [Abstract][Full Text] [Related]
3. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
[TBL] [Abstract][Full Text] [Related]
4. Ferrocene-Appended Iridium(III) Complexes: Configuration Regulation, Anticancer Application, and Mechanism Research.
Ge X; Chen S; Liu X; Wang Q; Gao L; Zhao C; Zhang L; Shao M; Yuan XA; Tian L; Liu Z
Inorg Chem; 2019 Oct; 58(20):14175-14184. PubMed ID: 31559820
[TBL] [Abstract][Full Text] [Related]
5. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z
Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276
[TBL] [Abstract][Full Text] [Related]
6. Fluorescent iridium(iii) coumarin-salicylaldehyde Schiff base compounds as lysosome-targeted antitumor agents.
Liu C; Liu X; Ge X; Wang Q; Zhang L; Shang W; Zhang Y; Yuan XA; Tian L; Liu Z; You J
Dalton Trans; 2020 May; 49(18):5988-5998. PubMed ID: 32314774
[TBL] [Abstract][Full Text] [Related]
7. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria.
Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J
Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145
[TBL] [Abstract][Full Text] [Related]
8. The Fluorine Effect in Zwitterionic Half-Sandwich Iridium(III) Anticancer Complexes.
Yang Y; Guo L; Ge X; Zhu T; Chen W; Zhou H; Zhao L; Liu Z
Inorg Chem; 2020 Jan; 59(1):748-758. PubMed ID: 31808678
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of anticancer effect in vitro and in vivo of iridium(III) complexes on gastric carcinoma SGC-7901 cells.
Zhang WY; Wang YJ; Du F; He M; Gu YY; Bai L; Yang LL; Liu YJ
Eur J Med Chem; 2019 Sep; 178():401-416. PubMed ID: 31202128
[TBL] [Abstract][Full Text] [Related]
10. Ferrocene-modified half-sandwich iridium(III) and ruthenium(II) propionylhydrazone complexes and anticancer application.
Ji C; Dong R; Zhang P; Tao R; Wang X; Dai Q; Liu X; Yuan XA; Zhang S; Yue M; Liu Z
J Inorg Biochem; 2024 Aug; 257():112586. PubMed ID: 38728860
[TBL] [Abstract][Full Text] [Related]
11. Rhodamine-modified fluorescent half-sandwich iridium and ruthenium complexes: potential application as bioimaging and anticancer agents.
Ma W; Guo L; Tian Z; Zhang S; He X; Li J; Yang Y; Liu Z
Dalton Trans; 2019 Apr; 48(15):4788-4793. PubMed ID: 30892340
[TBL] [Abstract][Full Text] [Related]
12. The anticancer application of half-sandwich iridium(III) ferrocene-thiosemicarbazide Schiff base complexes.
Liu X; Lv A; Zhang P; Chang J; Dong R; Liu M; Liu J; Huang X; Yuan XA; Liu Z
Dalton Trans; 2024 Jan; 53(2):552-563. PubMed ID: 38054240
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization and anticancer activity in vitro and in vivo evaluation of an iridium (III) polypyridyl complex.
Yi QY; Wan D; Tang B; Wang YJ; Zhang WY; Du F; He M; Liu YJ
Eur J Med Chem; 2018 Feb; 145():338-349. PubMed ID: 29331805
[TBL] [Abstract][Full Text] [Related]
14. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
[TBL] [Abstract][Full Text] [Related]
15. Anticancer and antibacterial activity in vitro evaluation of iridium(III) polypyridyl complexes.
Yi QY; Zhang WY; He M; Du F; Wang XZ; Wang YJ; Gu YY; Bai L; Liu YJ
J Biol Inorg Chem; 2019 Mar; 24(2):151-169. PubMed ID: 30564887
[TBL] [Abstract][Full Text] [Related]
16. Design and anticancer behaviour of cationic/neutral half-sandwich iridium(III) imidazole-phenanthroline/phenanthrene complexes.
Lv A; Li G; Zhang P; Tao R; Li X; Ren X; Li P; Liu X; Yuan XA; Liu Z
J Inorg Biochem; 2024 Aug; 257():112612. PubMed ID: 38761579
[TBL] [Abstract][Full Text] [Related]
17. Half-sandwich Iridium(III) Benzimidazole-Appended Imidazolium-Based N-heterocyclic Carbene Complexes and Antitumor Application.
Han Y; Liu X; Tian Z; Ge X; Li J; Gao M; Li Y; Liu Y; Liu Z
Chem Asian J; 2018 Dec; 13(23):3697-3705. PubMed ID: 30276978
[TBL] [Abstract][Full Text] [Related]
18. Anticancer application of ferrocene appended configuration-regulated half-sandwich iridium(III) pyridine complexes.
Wang Z; Lv Z; Liu X; Wu Y; Chang J; Dong R; Li C; Yuan XA; Liu Z
J Inorg Biochem; 2022 Dec; 237():112010. PubMed ID: 36152469
[TBL] [Abstract][Full Text] [Related]
19. Dual functions of iridium(III) 2-phenylpyridine complexes: Metastasis inhibition and lysosomal damage.
Liu X; Chen S; Ge X; Zhang Y; Xie Y; Hao Y; Wu D; Zhao J; Yuan XA; Tian L; Liu Z
J Inorg Biochem; 2020 Apr; 205():110983. PubMed ID: 31954343
[TBL] [Abstract][Full Text] [Related]
20. Studies of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes-loaded liposomes as drug delivery system.
Zhang WY; Du F; He M; Bai L; Gu YY; Yang LL; Liu YJ
Eur J Med Chem; 2019 Sep; 178():390-400. PubMed ID: 31202127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]